AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Generation of CTL Lines with Specificity Against Multiple Tumor Antigens

Technology Benefits

- Multi-TAA CTLs are polyclonal in antigen recognition, polyfunctional for cytokine production, and cytolytic against tumor cells.- Multi-TAA CTLs can be generated from both healthy donors and cancer patients, irrespective of HLA genotype, significantly broaden its potential clinical application.- Besides lymphoma, with different combinations of TTAs, this strategy may be used to target various types of cancers.

Detailed Technology Description

Publications:Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma. Gerdemann U, Katari U, Christin AS, Cruz CR, Tripic T, Rousseau A, Gottschalk SM, Savoldo B, Vera JF, Heslop HE, Brenner MK, Bollard CM, Rooney CM, Leen AM. Mol Ther. 2011 Dec;19(12):2258-68.

Country/Region

USA

For more information, please click Here